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Objective—The investment of newly formed endothelial cell tubes with differentiated smooth muscle cells (SMC) is
critical for appropriate vessel formation, but the underlying mechanisms remain unknown. We previously showed that
depletion of focal adhesion kinase (FAK) in the nkx2.5 expression domain led to aberrant outflow tract (OFT)
morphogenesis and strove herein to determine the cell types and mechanisms involved.
Methods and Results—We crossed fakloxp targeted mice with available Cre drivers to deplete FAK in OFT SMC (FAKwnt
and FAKnk) or coronary SMC (FAKcSMC). In each case, depletion of FAK led to defective vasculogenesis that was
incompatible with postnatal life. Immunohistochemical analysis of the mutant vascular structures revealed that FAK was
not required for progenitor cell proliferation, survival, or differentiation into SMC but was necessary for subsequent
SMC recruitment to developing vasculature. Using a novel FAK-null SMC culture model, we found that depletion of
FAK did not influence SMC growth or survival, but blocked directional SMC motility and invasion toward the potent
endothelial-derived chemokine, platelet-derived growth factor PDGFBB. FAK depletion resulted in unstable lamelli-
podial protrusions due to defective spatial-temporal activation of the small GTPase, Rac-1, and lack of Rac1-dependent
recruitment of cortactin (an actin stabilizing protein) to the leading edge. Moreover, FAK null SMC exhibited a
significant reduction in stimulated extracellular matrix degradation.
Conclusion—FAK drives PDGFBB-stimulated SMC chemotaxis/invasion and is essential for SMC to appropriately populate
the aorticopulmonary septum and the coronary vascular plexus. (Arterioscler Thromb Vasc Biol. 2011;31:2193-2202.)
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The investment of newly formed endothelial cell tubeswith differentiated smooth muscle cells (SMC) is a very
important process during vessel formation and requires intri-
cate regulation of SMC specification, motility, growth, and
differentiation. Failure of SMC recruitment to and migration
along developing vessels can lead to vascular instability and
regression, an event that is likely due in part to the ability of
these cells to secrete and organize extracellular matrix-
containing basement membranes and elastin. Moreover, ma-
ture medial SMC express high levels of contractile genes (ie,
myosin heavy chain, -smooth muscle actin (-SMA), SM22
among others) and their presence is essential for maintaining
vessel tone and for providing dynamic control of blood
pressure (see1 for review).
Although the precise signaling pathways have yet to be
identified, a number of major extrinsic factors have been
shown to regulate SMC recruitment and function. TGF-,
which promotes SMC differentiation,2–4 and platelet-derived
growth factor (PDGF), which promotes SMC growth and
motility, are both important extrinsic regulators of SMC
phenotype and genetic ablation of receptors for these genes
resulted in defective outflow tract (OFT) or coronary vascular
morphogenesis.5–7 Extensive evidence indicates that extracel-
lular matrix signaling is also an important regulator of SMC
growth and differentiation as deletion of either fibronectin,
the 5 integrin FN receptor, or focal adhesion kinase (FAK)
(the kinase that mediates 5-dependent signaling) each re-
sults in extraembryonic and embryonic vessel defects leading
to lethality in the mouse from E8.5 to E10.8–10
Although a direct role for FAK in vascular smooth muscle
growth and development has yet to be examined, our labo-
ratory recently showed that depletion of FAK from nkx2.5-
expressing precursors led to perinatal lethality resulting from
a profound subaortic ventricular septal defect accompanied
(in some neonates) by malalignment of the OFT including
double-outlet right ventricle and persistent truncus arteriosus
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Figure 1. Focal adhesion kinase (FAK) deletion impairs recruitment of cardiac neural crest-derived smooth muscle cells (SMC) to the
developing aorta and pulmonary artery. A, H&E staining of genetic control and FAKwnt mice at postnatal day 0 (P0). FAKwnt outflow
tract (OFT) shows persistent truncus arteriosus (PTA) and ventricular septal defect (VSD). LA indicates left atrium; RA, right atrium; Ao,
aorta; PT, pulmonary trunk; IVS, intraventricular septum. B, C, SM22 immunostaining (brown) of embryonic day 14 (E14; B) or P0 (C)
genetic control and FAKwnt OFT revealed PTA without defect in SMC differentiation. D, Proximal OFT of genetic control and FAKwnt
hearts at E 12 reveals colocalization of -SMA (red) with the cardiac neural crest lineage marker CRABP1 (green), indicating that the
SMC covering the aorta and pulmonary artery were derived from cardiac neural crest cells. X-gal staining demarcates wnt-1–derived
cardiac neural crest in the Rosa26RLacZ–positive embryos. Nuclei (blue) were stained with DAPI. Note the lack of SMC coverage
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(PTA).11 Thus, conditional inactivation of FAK in nkx2.5-
expressing cells phenocopies the most common congenital
heart disease that is also a subset of abnormalities associated
with Tetralogy of Fallot and the DiGeorge Syndrome.12,13
However, whether these defects arose from the inability of
nkx2.5 precursor cells to differentiate into SMC or from a
specific defect in nkx2.5-derived SMC remained unclear.
The aim of the present study was to identify the critical
FAK-dependent functions during vasculogenesis. Because
both wnt-1- and nkx2.5-expressing cells contribute to devel-
opment of conotruncal septal SMC that divide the OFT into
the aorta and pulmonary artery,13,14 we explored the effects of
FAK depletion in both origins using available Cre lines. We
show FAK deletion (by homologous recombination) in either
embryological origin results in OFT defects including PTA.
Moreover, targeted depletion of FAK in these SMC precur-
sors did not affect progenitor cell proliferation, survival, or
differentiation but resulted in lack of appropriate SMC
coverage of the developing vasculature. Similarly, depletion
of FAK in a third SMC precursor origin, the wt1-expressing
epicardial cells that provide SMC that line coronary vessels,
did not affect SMC specification but led to aberrant recruit-
ment of SMC to the developing coronary vasculature. Col-
lectively, these studies indicate that FAK is essential for a
SMC autonomous function during vascular remodeling. Our
mechanistic studies in FAK null SMC, revealed that FAK
does not influence SMC growth or survival but functions to
promote directional SMC chemotaxis/invasion toward the
potent endothelial-derived chemokine, PDGF.
Methods
Experimental Animals
fak/ mice15 were bred to existing Cre lines including cardiac
neural crest (CNC)-specific wnt-1Cre mice obtained from Andrew
McMahon14; primary and secondary heart field-specific nkx2.5Cre
mice obtained from Robert Schwartz16; and epicardial-specific
wt1Cre mice obtained from John Burch.17 The resulting fak//Cre
mice were bred with fakflox/flox/Rosa26RlacZ/lacZ mice to obtain fakflox/
Cre//Rosa26RlacZ/wt (experimental) or genetic control mice (fakflox//
Rosa26RlacZ/wt without Cre and fakflox/ with or without Cre). Mice
were housed in the University of North Carolina Animal Care
Facility, which is accredited by the Association for Assessment and
Accreditation of Laboratory Animal Care International, and all
experimental procedures were approved by the University of North
Carolina Animal Care and Use Committee.
Statistical Analysis
All quantitative data represent at least 3 separate experiments and are
presented as meanSEM. Means were compared by 2-tailed Student
t test. P0.05 was considered statistically significant.
See Supplemental Data Section for additional experimental pro-
cedures, available at http://atvb.ahajournals.org.
Results
FAK Deletion Impairs Recruitment of nkx2.5- and
wnt-1–Derived SMC to the Developing Aorta and
Pulmonary Artery
We previously showed that conditional deletion of FAK in
nkx2.5-expressing cells (FAKnk) resulted in malalignment of
the OFT and incomplete aorticopulmonary septum formation
in a percentage of neonates.11 Because nkx2.5-derived SMC
contribute to the formation of the aortic root and septum, we
hypothesized that this phenotype may have resulted from a
SMC defect in FAK-depleted cells. To further examine
FAK’s role in OFT development, we used the wnt-1Cre line to
deplete FAK from the CNC-derived SMC that also make a
major contribution to this process.14 These well characterized
mice generate high-efficiency recombination around E9.5 in
the CNC-derived cells populating the truncus arteriosis and
pharyngeal arch arteries (3, 4, and 6) and in the CNC-derived
cells invading the conotruncal cushions and the aorticopul-
monary septum by E11.5.14 Although fakflox/wnt-1Cre//
Rosa26RlacZ/wt mice (herein referred to as FAKwnt) were
present at the appropriate Mendelian ratio at P0 (Supplemental
Table I), all FAKwnt mice died within a few days after birth.
Gross morphology of the cardiac OFT revealed aberrant septa-
tion and branching of the major outflow vessels in all FAKwnt
mice with the majority (95%; N42/44) exhibiting PTA (Figure
1A). Thus, our data indicate that FAK activity in nkx2.5- and
wnt-1–derived cells is required for appropriate septation of the
truncus arteriosis.
Because the aortic arch defects observed in CNC-targeted
Notch/ mice were associated with impaired SMC differ-
entiation within the truncus,18 we tested whether FAK deple-
tion affected this process in our models. Expression of
-SMA in the pharyngeal arch region at E11 was similar
between control and FAKwnt mice (Supplemental Figure IA).
The unseptated ascending OFT in FAKwnt mice contained
layers of SM22-positive medial SMC that were comparable
to littermate controls from E14 onwards (Figure 1B and 1C).
SMC layers and differentiation in the carotid arteries also
appeared to be normal in FAKwnt mice (Supplemental Figure
IB). These mice were bred to contain the Rosa26RLacZ allele
to track progenitors of the Cre-expressing cells, and the
neural crest origin of carotids was confirmed by
-galactosidase positive staining (Figure S1C). In addition, as
shown in Supplemental Figure ID, SMC investment of
coronary SMC (that were not targeted for FAK depletion)
was also similar between genetic control and FAKwnt hearts,
indicating that global changes in flow or hemodynamic
properties do not account for the SMC investment phenotypes
observed in the FAKwnt OFTs.
Aorticopulmonary septation occurs between E11.5 and
E12.5 when a wedge of CNC-derived SMC partitions the
aortic sac into distinct aortic and pulmonary channels.19 To
more closely evaluate this process in FAKwnt mice, serial
sections were costained for -SMA and CNC lineage markers
(CRABP1 or expression of the Rosa26RLacZ allele). As
shown in Figure 1D, the SMC lining the pulmonary artery
and aorta at the level of the proximal OFT are mainly derived
from CNC in control and FAKwnt mice. However, a selective
lack of CNC (and CNC-derived SMC) was apparent in the
aortic wall juxtaposed to pulmonary artery in the FAKwnt
Figure 1 (Continued). (highlighted in white boxes) in the inner walls of the aorta and pulmonary artery in FAKwnt mice. E, Distal OFT at
E 12 stained with X-gal (blue in bright field), FAK (green), and -SMA (red) reveals FAK-depleted cardiac neural crest differentiate into
SMC (arrows) but fail to appropriately populate the conus. Nuclei (blue) were stained with DAPI. Scale bar100 m. LV indicates left
ventricle; RV, right ventricle.
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mice (Figure 1D; highlighted in box). FAK deficient CNC
cells populated the conotruncal region dorsal to the PTA and
properly differentiated into SMC (Figure 1E). However, in
FAKwnt mice the SMC in the dorsal conus were more
centrally located (Figure 1E; arrow) and did not surround the
developing vessels as completely in control mice.
We previously showed that FAK deficiency did not alter
proliferation or survival within the affected OFTs of FAKnk
mice.11 Similarly, there was no significant difference in levels
of cell death in the OFT of E13.5 FAKwnt mice in comparison
to controls (27.84.3 versus 29.37.4 per 0.5 mm2, respec-
tively; N5/5). The numbers of BrdU-labeled cells in the
affected OFT region of FAKwnt embryos also did not differ
significantly from those in the genetic controls (45.8 /3.7
versus 43.6 /4.8 per 0.5 mm2, respectively; N4/4). In
support of a lack of major effect on the proliferation and
survival of CNC-derived cells, the more distal CNC-derived
structures such as the aforementioned carotid arteries (Sup-
plemental Figure IB and IC) and other neural crest-derived
structures including the thymic lobes, thyroid, tongue, and ear
appeared to be unaffected by FAK deletion (data not shown).
Close evaluation of the cranial cartilage and bones did reveal a
modest mandibular truncation in 3/6 FAKwnt neonates, but the
crown-rump length and maxilla formation were normal (Sup-
plemental Figure IE). Collectively, these studies reveal that CNC
functions, population of the developing OFT, and differentiation
of wnt-1 lineages into SMC occur normally in FAKwnt mutants.
However, in these mice and those in which FAK was depleted in
nkx2.5-derived cells, FAK null SMC fail to appropriately invest
the inner walls of the developing aorta and pulmonary trunk,
indicating that FAK may be necessary for directional SMC
movement within the conotruncus.
FAK Deletion Impairs Recruitment of
Epicardial-Derived SMC to the Coronary Plexus
To provide additional in vivo evidence for our hypothesis, we
tested the effects of FAK depletion on the recruitment of
epicardial-derived SMC to the intramyocardial endothelial
plexus, a process also dependent on directional motility.7 To
this end, we intercrossed our FAKflox/flox/Rosa26RlacZ/lacZ
mice to an available Wilm’s Tumor-1Cre line (wt-1, hereafter
referred to as FAKcSMC so as to not be confused with FAKwnt)
that induces strong and uniform recombination in the proepi-
cardium by E9.5 and is restricted to the epicardium from
E10.5 onward.17,20 Previous studies revealed that wt1-derived
cells give rise to the SMC that invest the coronary arteries and
veins,7,20 and we found similar results on analysis of
-galactosidase expression in P0 wt1Cre/Rosa26RLacZ hearts
(Supplemental Figure II). We observed Mendelian distribu-
tion of FAKcSMC at P0 (Supplemental Table I), but all
FAKcSMC mice died within a few days after birth by still to be
determined mechanisms.
Importantly, immunohistochemical assessment of -SMA
positive cells in P0 hearts, revealed a striking and consistent
lack of SMC coverage of the coronary endothelial plexus
(Figure 2). All large diameter vessels in FAKcSMC hearts
exhibited a thin noncontinuous layer of SMC in comparison
to comparable genetic control vessels (Figure 2B, arrow-
heads), although most of the smaller arterioles exhibited a
Figure 2. Focal adhesion kinase (FAK) deletion impairs recruit-
ment of epicardial-derived smooth muscle cells (SMC) to the
coronary vessels. A, P0 genetic control and FAKcSMC heart
stained with FAK (green) and -SMA (red). Phase image is
shown on left. Subepicardial -SMA-stained cells (arrows) are
present in FAKcSMC but not genetic control hearts. Scale
bar40 m. Boxed regions (a’-e’) in A are shown at higher
magnification in B. B, FAKcSMC hearts exhibited reduced pres-
ence of SMC lining the coronary vasculature, including large
vessels (arrowheads) and small arterioles (arrows), in compari-
son to genetic control vessels. FAK deletion was confirmed by
absence of FAK staining in SMC from FAKcSMC hearts (arrow-
heads). Scale bar20 m or 10 m. C–E, Numbers of SMC lin-
ing arteries (diameter 65 m), arterioles (diameter 65 m as
previously described45), or localized in the subepicardium were
quantified using Image J. *P0.05; **P0.01.
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complete lack of associated SMC (Figure 2B, arrows).
Quantification of SMC numbers revealed significantly fewer
SMC associated with both arteries and arterioles in FAKcSMC
hearts relative to genetic controls (Figure 2C,D). In contrast,
significantly higher numbers of -SMA positive cells were
observed in the subepicardial space in FAKcSMC, compared to
genetic control hearts (Figure 2A, arrows, Figure 2E), indi-
cating that the FAK null cells efficiently delaminated from
the epicardium and differentiated into SMC, but failed to migrate
into the myocardium. Importantly, a reduction in platelet/endo-
thelial cell adhesion molecule labeled coronary vasculature was
not observed in the FAKcSMC hearts (Figure 3), indicating
appropriate formation of the primary plexus. This conclusion is
supported by the finding that these hearts did not exhibit signs of
hypoplastic growth or noncompaction that are associated with
defects in endothelial plexus function (Supplemental Figure IIIA
and IIIB).21 As well, no defects in the formation or SMC
investment in carotid arteries (not targeted for FAK depletion)
were observed in the FAKcSMC neonates, indicating a lack of
effect on global hemodynamics (Supplemental Figure IIIC).
We next performed additional studies to confirm that
FAK activity was not required for the proliferation or
survival of SMC progenitors, or their differentiation into
coronary SMC. As shown in Supplemental Figure IVB,
there was no statistical difference in the rates of cell
proliferation or apoptosis in -gal labeled wt-1-derived
cells within FAKcSMC hearts compared to genetic controls
at either E15.5 or P0. Interestingly, by E15.5, many -gal
labeled cells in genetic control hearts had moved into the
subepicardial zone, whereas most of the -gal labeled cells
in E15.5 FAKcSMC hearts remained associated with the
epicardium (Supplemental Figure IVA), corroborating our
previous findings in the P0 hearts that suggested impaired
directional motility of the FAK-depleted SMC (Figure 2B
and 2E). We also analyzed SMC differentiation marker
gene expression in quail proepicardial organ explants
treated with adenoviruses that express GFP or the FAK
inhibitor, GFP-FRNK. As shown in Supplemental Figure
V, expression of FRNK attenuated the outward movement
of the epicardial explants but did not affect the induction of
SMC marker gene expression in these cultures. These
studies strongly suggest that the SMC investment defect
observed in FAKcSMC coronary vessels did not result from
a block in the proliferation, survival, or differentiation of
wt-1 progenitors but rather from a lack of SMC recruitment
to the endothelial plexus.
FAK Deletion Impairs SMC Chemotaxis but not
Proliferation or Survival
To confirm that FAK plays a significant role in the regulation
of SMC chemotaxis, we established a conditional FAK null
SMC culture model using cells isolated from fakflox/flox mice.
As shown in Figure 4A, treatment of fakflox/flox SMC with Cre
adenovirus (but not LacZ) resulted in a significant reduction
of FAK protein. In excellent agreement with our in vivo
studies, FAK deletion had no effect on SMC differentiation
marker gene expression (Figure 4A) and, importantly, did not
alter the expression of FRNK or the FAK homologue, Pyk2
(Supplemental Figure VIA). Moreover, continuously adher-
ent FAK null cells revealed no major differences in focal
adhesion or actin filament organization (Supplemental Figure
VIB).
Because the strongly chemotactic PDGFs are highly ex-
pressed in the conotruncus during OFT and coronary vessel
morphogenesis, and have been implicated in guiding cells
during these critical processes,5,22 we hypothesized that the
cause of the PTA (in FAKwnt and FAKnk mice) and the
impaired coronary vessel formation (in FAKcSMC mice) was
Figure 3. Endothelial plexus formation in focal adhesion kinase
(FAK)cSMC hearts. P0 genetic control and FAKcSMC hearts
stained with endothelial marker platelet/endothelial cell adhesion
molecule (PECAM) (green) and -SMA (red) showing normal en-
dothelial plexus formation with reduced smooth muscle cell cov-
erage (arrowhead) of the coronary endothelial plexus. Nuclei
(blue) were stained with DAPI. Boxed regions (a’-c’) in A are
shown at higher magnification in B. Scale bar40 m (A) and
10 m (B), respectively.
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due to a defective SMC migratory response to this chemo-
kine. We found that PDGF treatment induced robust FAK
activation at the leading edge of SMC (Figure S6C) and that
FAK was necessary for PDGF-stimulated SMC chemotaxis
as assessed using fibronectin-coated transwells (Figure 4B).
Chemotaxis toward serum was also inhibited but this effect
was much more modest (Figure 4C). Importantly, ectopic
expression of wildtype FAK but not phosphorylation-
deficient FAK (Y397FFAK) restored PDGF-stimulated motil-
ity in FAK-deficient cells (Figure 4D). Confirming our in
vivo results, we detected no significant difference in cell
proliferation between control and FAK null SMC grown in
10% serum (data not shown), under serum-free conditions, or
following treatment with PDGF or EGF (Supplemental Fig-
ure VID). Accordingly, PDGF receptor activation (as as-
sessed by staining and Western analysis for pY716PDGFR;
data not shown), PDGF-stimulated ERK activity (Supple-
mental Figure VIE) and cyclin D protein levels (Supplemen-
tal Figure VIF) were similar in Cre- and LacZ-treated cells,
indicating that FAK was not required for activation of the
major mitogenic Ras/ERK signaling pathway. We also ob-
served no significant difference in cell survival in FAK-
depleted SMC as measured by caspase 3/7 activity (data not
shown). As well, PDGF-stimulated activation of the prosur-
vival kinase, AKT was unchanged (data not shown). Collec-
tively, these data indicate that defective aorticopulmonary
septation and coronary vasculogenesis observed in our con-
ditional FAK mutants was likely due to a specific defect in
PDGF-dependent SMC chemotaxis.
FAK Increases Lamellipodial Stability Through
Rac1-Dependent Recruitment of Cortactin
Because PDGF-dependent motility involves rapid remodeling
of the plasma membrane and underlying actin cytoskeleton,
we next explored whether FAK-depleted SMC exhibited a
biomechanical defect in one of these processes. To this end,
we performed time-lapse imaging of Cre- and LacZ-treated
fakflox/flox SMC following PDGF treatment. In control cells,
PDGF stimulated extensive membrane ruffling as early as 2.5
minutes that culminated in formation of a dominant, stable
leading edge lamellipodium by 15 to 20 minutes (Figure 5A,
left). In contrast, PDGF treated FAK null SMC remained
unpolarized and rarely formed a distinctive leading edge
(Figure 5A, right). Kymographic analysis of lamellipodia
dynamics indicated that this difference was mainly due to
decreased lamellipodia persistence in FAK null SMC (Figure
5B-5D) and that this defect culminated in a significant
decrease in leading edge displacement (Figure 5E) and cell
speed in 2-D (Figure 5F).
PDGF-stimulated motility is dependent on Rac1, a small
GTPase that controls cell protrusion and lamellipodial dy-
namics. To test whether FAK is necessary for Rac1 activa-
tion, we first analyzed total Rac1 activation in response to
PDGF using the standard GST-PBD pull-down assay. As
shown in Supplemental Figure VIG, PDGF robustly and
transiently activated Rac1 with peak activity by 2.5 minutes
and, somewhat surprisingly, this response was not affected by
depletion of FAK. Thus, global activation of Rac1 is FAK-
independent. Because recent studies indicate that PDGF
induces leading edge localized activation of Rac1 via induc-
tion of new integrin-extracellular matrix connections,23 we
explored the idea that FAK might be necessary for restricting
localized Rac1 activity to the leading edge. Immunofluores-
cent staining with a Rac1 antibody revealed that PDGF
treatment of wildtype and FAK-deficient SMC led to rapid
and equivalent accumulation of Rac1 at dorsal ruffles that
peaked at 2.5 minutes (Figure 5G top, 5H). By 15 minutes
following PDGF-treatment, restricted enrichment of Rac1 at
the leading edge was observed in wildtype SMC, but this
response was perturbed in FAK null SMC, which exhibited
random distribution of membrane-associated Rac1 (Figure
5G bottom, 5I).
To confirm a role for FAK in localized Rac1 activation, we
next examined the spatiotemporal distribution of cortactin, an
actin binding protein that is recruited to the cell periphery in
a Rac1-dependent fashion.24 Immunofluorescent staining
showed that recruitment of cortactin to leading edge-
lamellipodia (Figure 5J bottom, 5L), but not dorsal ruffles
(Figure 5J top, 5K) was significantly reduced in FAK null
SMC, indicating that FAK is critical for this aspect of
PDGF-stimulated cytoskeletal remodeling. These data are
consistent with the finding that active FAK accumulates at
the leading edge of cells following PDGF treatment (Supple-
mental Figure VIC). Importantly, either blocking Rac1 activ-
ity with the pharmacological inhibitor NSC23766
(10 mol/L, Calbiochem) or treatment with cortactin siRNAs
mirrored the effects of depleting FAK on PDGF-stimulated
SMC membrane dynamics and chemotaxis (Supplemental
Figure VII). In sum, these studies indicate that FAK plays a
Figure 4. Focal adhesion kinase (FAK) deletion impairs smooth
muscle cell chemotaxis/invasion toward platelet-derived growth
factor (PDGF) and serum. A, fakflox/flox SMC were infected with
either LacZ or Cre adenovirus for 72 hours and cell lysates were
immunoblotted with antibodies for smooth muscle differentiation
markers (smooth muscle myosin heavy chain (SM-MHC) and
-SMA). Alpha-tubulin was used as a loading control. Data are
representative of at least 4 experiments. B–D, Cells treated as
above were plated on fibronectin-coated inserts (10 g/mL; Bio-
Coat) in serum-free media using either PDGF-BB (20 ng/mL; B)
or 10% serum (C) as the chemoattractant. D, LacZ- or Cre-
infected cells were cotransfected with GFP and either Flag vec-
tor control, Flag-FAK, or the inactive mutant Flag-Y397FFAK.
Chemotaxis toward PDGF-BB was assessed 24 hours after
transfection. Wild-type FAK but not Y397FFAK restored che-
motaxis toward PDGF in the Cre expressing cells. Results in
B–D are meanSEM of cells counted in 4 fields from 4 inde-
pendent experiments. *P0.05; ***P0.001.
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critical role in coordinating and stabilizing the protein com-
plexes that are required for Rac1-dependent leading edge
protrusions, and hence, directional SMC motility toward the
potent endothelial-derived chemokine, PDGF.
FAK Is Necessary for SMC-Mediated
Extracellular Matrix Degradation
SMC are known to have a high basal invasive potential,25 a
function mediated by podosomes, sites of dynamic actin
polymerization activity thought to be the topological equiv-
alent of lamellipodia formed during 3D movement. Interest-
ingly, podosomes are initiated at the inner-face of focal
adhesion complexes and require cortactin and its associated
Arp 2/3 complex for extension into the underlying matrix and
for the recruitment and secretion of matrix-degrading pro-
teases.26,27 To determine whether the chemotactic defect of
FAK null SMC in the Boyden chamber assays resulted from
impaired directional movement alone or to a combination of
impaired motility and invasion, we assessed the capacity of
wt and FAK null SMC to degrade extracellular matrix. To
this end, we cultured LacZ- or Cre-adenovirus pretreated
fakflox/flox SMC on fluorescent matrix (Oregon green 488
gelatin/fibronectin mixture) and treated them with or without
PDGF for 90 minutes. As shown in Figure 6A, PDGF
induced focal areas of matrix degradation (cell associated
dark spots) in wt SMC, but this response was significantly
Figure 5. Focal adhesion kinase (FAK) regulates Rac1-
dependent cortactin recruitment and lamellipodial stability.
LacZ- or Cre-infected fakflox/flox SMC were treated with 20
ng/mL platelet-derived growth factor (PDGF)-BB and immedi-
ately imaged at 5-second intervals for 60 minutes. A, Represen-
tative images of cells 20 minutes following PDGF treatment. Cell
polarization as shown by formation of leading edge (arrowhead)
and trailing edge (arrow) was observed in control but not in
FAK-deficient smooth muscle cells. B, Representative kymo-
graphs of LacZ and Cre-infected cells 0 to 20 minutes following
PDGF-BB treatment. Ascending slopes represent protrusion
(arrows) and descending slopes represent retraction (arrow-
heads). C–E, Kymographic analysis of lamellipodial dynamics
following PDGF treatment. Calculated protrusion rate (C), lamel-
lipodial persistence (D), and leading edge displacement (E) from
8 to 10 cells from 4 independent experiments (meanSEM;
*P0.05). F, Average 2D cell speed within 4 hours following
PDGF treatment. Results are mean SEM of 30 to 60 cells from
4 independent experiments. *P0.05. G–I, LacZ or Cre infected
fakflox/flox cells stained for Rac1 showing dorsal ruffle localization
in both control (G, top left) and FAK-deficient (G, top right) cells
at 2.5 minutes following PDGF treatment. At 15 minutes, leading
edge localization of Rac1 (arrows) was observed in control cells,
whereas FAK-deficient cells showed unpolarized Rac1 localization
(arrowheads). H, I, Quantification of cells exhibiting Rac1-labeled
dorsal ruffles 2.5 minutes post-PDGF treatment (H) and Rac1-
labeled dominant leading edge lamellipodia 15 minutes post-PDGF
treatment (I). Results are meanSEM of 150 to 200 cells from 3
independent experiments. ***P0.001. J–L, Smooth muscle cells
treated as above were stained with anticortactin antibody and pro-
cessed as described in G–I. Similar dorsal ruffle but not leading
edge recruitment of cortactin was observed in FAK-deficient cells.
Results are meanSEM of 200 to 250 cells from 4 independent
experiments. **P0.01. Scale bar10 m.
Figure 6. Focal adhesion kinase (FAK) is necessary for smooth
muscle cell (SMC)-mediated extracellular matrix degradation. A,
LacZ- or Cre-infected fakflox/flox SMC were plated on Oregon
Green 488 gelatin/ fibronectin matrix in serum-free medium and
treated with vehicle or platelet-derived growth factor (PDGF)-BB
for 90 minutes. Cells were fixed and costained with anti-FAK
antibody and phalloidin. B, Cells were scored for the presence
of degradation puncta (black spots) and data are presented as
puncta/cell normalized to values for the LacZ-infected SMC fol-
lowing PDGF treatment. Data represent meanSEM of at least
200 cells from 3 independent experiments. *P0.05. C, LacZ- or
Cre-infected fakflox/flox SMC were plated on DQ-gelatin-coated
96-well plate and treated with PDGF-BB for 90 minutes. Fluores-
cence intensity was monitored at Ex/Em 495/515 nm. Data repre-
sent meanSEM of 3 independent experiments. *P0.05. D, GFP
and LacZ or Cre coinfected fakflox/flox SMC were treated as above
were plated on matrigel-coated inserts (10 g/mL; Bio-Coat) in
serum-free media using either PDGF-BB (20 ng/mL) as the che-
moattractant. Invading cells were counted by direct fluorescence at
10 magnification. Data represent meanSEM of 3 independent
experiments. ***P0.001.
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diminished in FAK-deficient SMC. We next evaluated the
ability of FAK-containing and FAK null SMC to degrade
DQ-gelatin, which fluoresces on degradation allowing quan-
tification of protease activity via fluorescent spectrophotom-
etry. As shown in Figure 6C, significantly lower levels of
gelatin degradation occurred in FAK-depleted SMC com-
pared to control SMC, confirming that SMC matrix protease
activity is FAK-dependent. In addition, we found that inva-
sion of FAK null SMC into matrigel was significantly
impaired in comparison to wt SMC (Figure 6D). These
studies indicate that FAK is necessary for both PDGF-
stimulated chemotaxis and invasive cell migration; and may
explain, at least in part, the selective requirement for FAK in
coronary and OFT morphogenesis, as these processes each
require SMC to cross tissue/extracellular matrix boundaries.
Discussion
Our studies using 3 independent Cre lines that induce
recombination in SM precursor cells revealed a SMC auton-
omous role for FAK in vascular development. Depletion of
FAK in wnt-1- and nkx2.5-derived cells (ie, FAKwnt and
FAKnk embryos, respectively) led to aberrant septation of the
great vessels; although depletion of FAK in proepicardial
wt1-derivatives (ie, FAKcSMC embryos) led to defective
coronary vascular formation. Concomitantly, the OFT and
coronary vessels were distended by P0, likely due to a block
in vessel tone normally imparted by SMC and SMC-
elaborated basement membrane components. Phenotypic as-
sessment of each mouse model revealed that the FAK-null
SMC were specified but failed to be appropriately recruited to
established endothelial tubes. Our studies using FAK-null
SMC cultures revealed a selective function for FAK in
regulating PDGF-dependent motility but not growth or sur-
vival. Specifically, we found that FAK depletion decreased
PDGF-stimulated leading edge persistence, cell migration
speed, and directional chemotaxis. Given the fact that block-
ade of PDGF led to defects in recruitment of vascular SMC to
the developing vasculature28,29 and CNC- and epicardial-
targeted ablation of PDGF receptor /, led to fully penetrant
PTA and defective coronary vasculature respectively,5,7 we
speculate that the morphogenesis of these vascular structures
involves FAK-dependent SMC motility/chemotaxis induced
by endothelial derived PDGFs.
Interestingly, PTA has been associated with a block in
SMC differentiation within the truncus of mice harboring null
mutations in the BMP receptor, Alk-2 and MRTF-B, as well
as those with CNC-targeted expression of a dominant nega-
tive Notch variant.18,30–32 However, similar to our studies,
CNC-targeted ablation of TGFR2, PDGFBBR /, and Gata
6 each led to fully penetrant PTA without a noticeable
reduction in SMC number or SMC maturation.5,6,33 Interest-
ingly, the interrupted arch phenotype observed in CNC-
specific FAK knockout mice recently reported by Vallejo-
Illarramemdi et al was attributed to impaired SMC
differentiation of a subset of CNC (within the aortic arch),
although the authors observed normal differentiation of CNC
cells into SMC within the aorticopulmonary septum.34 Thus,
the underlying cause for impaired septation was not identified
in the aforementioned manuscript. As we did, this group
observed normal migration and growth of CNC in FAKwnt
embryos as well as normal differentiation of neural crest cells
into SMC within the aorticopulmonary septum. These find-
ings coupled with our mechanistic studies in FAK null SMC
suggest that precise regulation of SMC phenotype within the
walls of the aortic sac is necessary for subsequent formation
of the aorticopulmonary septum. Because PDGF29 and now
FAK have been implicated in the promotion of SMC che-
motaxis, it is tempting to speculate that the final septation
event may be due to coordinated movement of CNC-derived
SMC to the conus. Mis-localization of these cells could
therefore lead to impaired coverage of the OFT vessels and
impaired force generation within the conus that could impact
the dynamic morphogenetic movements during septogenesis.
Because formation of the OFT is extremely complex and
involves multiple cell types with interconnected functions, we
chose a separate in vivo model (coronary vasculogenesis) to
confirm a role for FAK in SMC chemotaxis. The epicardium
contains progenitor cells, the major source of SMC that will
eventually line the coronary vessels. Elegant lineage tracing
studies have shown that SMC precursors are specified in the
proepicardium before spreading of this epithelial tissue
around the heart.35–37 In response to signals from the myo-
cardium, these specified cells undergo an epithelial to mes-
enchyme transition, delaminate from the epicardium, and
move into the subepicardial space. Epicardial-derived mes-
enchymal cells will eventually be induced to migrate into the
myocardium and to differentiate into definitive cell types;
predominantly the SMC that cover the primary endothelial
plexus but also some endothelial and myocardial cells.20 The
endothelial primary plexus originates from the atrial-ventric-
ular groove at the base of the heart and gradually extends to
the apex between E11.5-E13.5 in response to prior wave-like
secretion of tropic factors from the myocardium (VEGFA and
B) and epicardium (sonic hedgehog)21, an event that is
necessary to support midgestational growth. Because the
investment of the coronary plexus with mature SMC occurs
in a similar (albeit delayed) spatial-temporal pattern, it has
been postulated that endothelial-derived factors initiate the
recruitment of epicardial-derived SMC. Although the spatial-
temporal coupling of epicardial-derived mesenchymal cell
differentiation and migration has not been well characterized,
the possibility that SMC differentiation may occur before
chemotaxis/invasion toward the endothelial plexus is sup-
ported by the recent finding that cardiac-restricted depletion
of the chemoattractant, thymosin -4 resulted in robust
-SMA stained cells that aberrantly lined the epicardium (at
E14.5 in mouse) but failed to invade the myocardium.38
The following findings from our studies support the hy-
pothesis that activation of FAK in SMC by endothelial-
derived signals regulates coronary SMC recruitment to (and
along) the developing arterioles: (1) Defects were observed in
SMC coverage of arterioles in FAKcSMC hearts but not in the
formation or function of the endothelial plexus (as assessed
by platelet/endothelial cell adhesion molecule staining and
appropriate midgestational heart growth); (2) no significant
difference was observed in either the rates of proliferation or
apoptosis in FAK-null precursor cells, and (3) significantly
higher numbers of -SMA-positive cells were apparent in the
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subepicardial space (as opposed to along the endothelial
plexus) of the conditional mutants at P0, indicating that FAK
was not essential for epicardial-mesenchymal transition but
was necessary for movement into the myocardium. These
findings coupled with our in vitro evidence that FAK is
necessary for chemotaxis/invasion toward the major endothe-
lial-derived chemo-attractant, PDGFBB, indicate that lack of
directional motility is likely causal for the SMC investment
phenotypes observed in the SMC-selective FAK knock-outs.
However, it is formally possible that defects in other param-
eters not evaluated herein could contribute to the defects
observed.
Our mechanistic studies revealed that depletion of FAK
markedly impaired PDGF-stimulated formation of a stable
leading edge lamellipodium, the hallmark of polarized move-
ment. This defect was accompanied by reduced leading edge
recruitment of cortactin, a branch filament stabilizer that is
essential for lamellipodial persistence and polarized motil-
ity.39 Moreover, cortactin knock-down was shown to affect
lammellipodial activity and directional chemotaxis in exactly
the same way as depletion of FAK, suggesting that the
functions of these two proteins are interrelated. Interestingly,
we found that formation of circular dorsal ruffles in response
to PDGF does not require Rac1 activation, cortactin, or FAK.
Although the function of these transient dorsal ruffles is not
completely understood, there is considerable support for the
idea that they are formed as a prelude to leading edge lamella
and are important for recruitment and recycling of membrane
and actin polymerizing/depolymerizing agents to the pre-
sumptive leading edge. Indeed, dorsal ruffles contain many of
the same actin regulating components as leading edge lamella
including (among others) ARP2/3, WASP1/2, WAVE, dy-
namin, and cofilin.40 We surmise that FAK regulates leading
edge and not dorsal ruffle formation because FAK is essential
for the spatial redistribution of active Rac1 from these
complexes to the leading edge.
Because FAK is one of the first proteins recruited to
nacient focal complexes, we surmise that FAK initiates
recruitment of active Rac1 to these newly formed sites via
multifunctional protein complex formation. FAK associates
with a number of adapter molecules through well-defined
protein interaction sites that could serve as a Rac1 binding
platforms. FAK-dependent recruitment of Rac1 could pro-
ceed through FAK/(CAS or paxillin)/Crk/DOCK 180 com-
plex formation41,42 or a paxillin/PIX/COOL complex.43
Whether FAK-dependent activation of Rac1 at the leading
edge is linked to the impaired spatial-temporal leading edge
specific redistribution (or phosphorylation) of these or other
FAK substrates are important questions for future studies.
There are a few possible explanations for why FAK might
be essential for SMC investment of the conotruncus and
coronary vasculature, but not for the recruitment of SMC to
the distal vasculature (ie, carotid arteries). First, there may be
cell type-specific differences in the factors that drive che-
motaxis or regional differences in the levels and locale of
these so-called motogens. In this regard, it is interesting to
note that SMC chemotaxis toward PDGF was exquisitely
sensitive to depletion of FAK, although chemotaxis toward
serum was only modestly decreased in FAK null SMC
(indicating that there are likely FAK-dependent and FAK-
independent SMC motogens). The findings that depletion of
PDGF receptors from CNC- or proepicardial cells phenocop-
ies the OFT and coronary vessel defects observed in our
FAK-depleted models and that PDGFs are expressed in high
levels within the conotruncus5–7 supports the possibility that
PDGF and FAK may work in concert to spatially regulate
SMC motility in these regions. The second (not mutually
exclusive) possibility is that a SMC invasive phenotype (that
requires FAK activity) is required for SMC to cross tissue
boundaries during both septal formation and coronary vascu-
logenesis (but not carotid vasculogenesis). Indeed, it may be
possible that SMC coverage of carotid vessels occurs by a
sheet-like movement/expansion of SMC along the continu-
ously remodeling SMC-lined pharyngeal arches. In support of
the possibility that FAK promotes an invasive phenotype, we
showed that FAK is necessary for SMC podosome-mediated
matrix degradation, and others have recently reported that
FAK is essential for invadopodia-mediated matrix degrada-
tion in colon cancer cells.44 Lack of appropriate cortactin
recruitment could also be causal for the impaired invasion
observed in the FAK null SMC because cortactin has been
shown to be necessary for regulating the localized recruit-
ment and secretion of matrix metalloproteinases from
lamellipodial-like membrane protrusions.26 Future studies
will be necessary to more fully understand the requirement
for SMC invasion versus chemotaxis during the formation of
various vascular beds.
In conclusion, our studies indicate that FAK plays a SMC
autonomous role in aorticopulmonary septum and coronary
vessel formation. Our studies in cultured SMC indicate that
FAK activity is critical for SMC chemotaxis/invasion toward
PDGF, a potent chemoattractant elaborated from the endo-
thelium. Thus, we surmise that defective PDGF-dependent
SMC recruitment leads to improper morphogenesis of FAK
null vessels. We found that FAK functions to induce direc-
tional SMC motility by regulating the spatial and temporal
locale of Rac1-dependent processes, including leading edge
recruitment of the actin modifier, cortactin, which is neces-
sary to stabilize lamellipodia and to form productive podo-
somes. It will be of future interest to evaluate the extent to
which FAK may play a role in the pathogenesis of microan-
eurysms and other vascular diseases associated with defective
recruitment of PDGF receptor  positive progenitors.28
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